NEW YORK–(BUSINESS WIRE)–Pfizer Inc. today announced the election of Joseph J. Echevarria to its Board of Directors, effective immediately. Mr. Echevarria also was appointed to the Audit, Regulatory and Compliance and Science and Technology Committees of Pfizer’s Board. Mr. Echevarria, 58, retired as Chief Executive Officer (CEO) of Deloitte LLP, a global provider of professional […]

CAMBRIDGE, Mass.–(BUSINESS WIRE)–Eleven Biotherapeutics, Inc. (Nasdaq: EBIO), a clinical-stage biopharmaceutical company discovering and developing protein therapeutics to treat diseases of the eye, today announced that Gregory D. Perry has resigned as Chief Financial and Business Officer, effective July 3, 2015. John J. McCabe, Eleven’s Vice President of Finance and Business Operations, is promoted to assume […]

PARSIPPANY, NJ–(Marketwired – Jun 24, 2015) – Ogilvy CommonHealth Worldwide (www.ochww.com), the health behavior change specialists of Ogilvy & Mather (www.ogilvy.com), and a WPP company (NASDAQ: WPPGY) (www.wpp.com), today announced two executive-level changes within management at the organization’s headquarters in Parsippany — with the appointment of Michael Zilligen as president of both Ogilvy CommonHealth Payer […]

AstraZeneca has lost a second senior executive in a fortnight with the departure of its respiratory and inflammatory medicines head James Ward-Lilley to become chief executive of lung drug specialist Vectura. His departure follows the exit earlier this month of Briggs Morrison, AstraZeneca’s former chief medical officer and head of late-stage drug development, who moved […]

AstraZeneca has lost a second senior executive in a fortnight with the departure of its respiratory and inflammatory medicines head James Ward-Lilley to become chief executive of lung drug specialist Vectura. His departure follows the exit earlier this month of Briggs Morrison, AstraZeneca’s former chief medical officer and head of late-stage drug development, who moved […]

WOONSOCKET, R.I., June 23, 2015 /PRNewswire/ — CVS Health (NYSE: CVS) today announced that Norman de Greve will join CVS Health as Chief Marketing Officer, effective July 15. In this role, de Greve will be accountable for marketing strategy across the enterprise.  Currently, President of the Boston and Detroit offices of DigitasLBi, an agency considered a […]

Ousted Sanofi (SNY) chief Christopher Viehbacher has found a warm welcome in his new adopted hometown of Boston, he said in a recent interview, where he will oversee Swiss billionaire Ernesto Bertarelli’s U.S. based Gurnet Point Capital fund, an announcement that came this week. Viehbacher told Bloomberg News this week that Bertarelli contacted him “within […]

BEAVERTON, Ore., June 23, 2015 /PRNewswire/ — Kryptiq, a market leader in population health management, announced today the appointment of Joseph Siemienczuk, MD, as its chief medical officer. In this capacity, Dr. Siemienczuk will partner with Kryptiq’s chief population health officer, Dr. Jacquelyn Hunt, to oversee the discovery, codification, and curation of the latest evidence based […]

June 23, 2015By Alex Keown, BioSpace.com Breaking News Staff BOULDER, Colo. – Andrew Allen, has stepped down from his role as chief medical officer at Clovis Oncology (CLVS) to launch his own immuno-oncology biotech company, Clovis said this week. Allen will remain with the company through August before departing to launch his company. During his […]

CAMBRIDGE, Mass.–(BUSINESS WIRE)–BIND Therapeutics, Inc. (NASDAQ: BIND), a clinical-stage nanomedicine company developing targeted and programmable therapeutics called Accurins™, today announced that Andrew Hirsch has been appointed president and chief executive officer of the Company. Mr. Hirsch had been serving in the role on an acting basis since March 2015. Mr. Hirsch has also been elected […]